» Articles » PMID: 16732013

Prevalence and Risk Factors for Urinary Incontinence in Women with Type 2 Diabetes and Impaired Fasting Glucose: Findings from the National Health and Nutrition Examination Survey (NHANES) 2001-2002

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2006 May 30
PMID 16732013
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Diabetes is associated with increased risk of urinary incontinence. It is unknown whether women with pre-diabetes, or impaired fasting glucose (IFG), have increased prevalence of incontinence. We determined the prevalence of, and risk factors for, incontinence among U.S. women with diabetes and IFG.

Research Design And Methods: The 2001-2002 National Health and Nutrition Examination Survey measured fasting plasma glucose and obtained information about diabetes and urinary incontinence among 1,461 nonpregnant adult women. Self-reported weekly or more frequent incontinence, both overall and by type (urge and stress), was our outcome.

Results: Of the 1,461 women, 17% had diabetes and 11% met criteria for IFG. Prevalence of weekly incontinence was similar among women in these two groups (35.4 and 33.4%, respectively) and significantly higher than among women with normal fasting glucose (16.8%); both urge and stress incontinence were increased. In addition to well-recognized risk factors including age, weight, and oral estrogen use, two microvascular complications caused by diabetes, specifically macroalbuminuria and peripheral neuropathic pain, were associated with incontinence.

Conclusions: Physicians should be alert for incontinence, an often unrecognized and therefore undertreated disorder, among women with diabetes and IFG, in particular those with microvascular complications. The additional prospect of improvements in their incontinence may help motivate some high-risk women to undertake difficult lifestyle changes to reduce their more serious risk of diabetes and its sequelae.

Citing Articles

Prevalence and risk factors of stress urinary incontinence in a 2023 Japanese community health survey - differences between males and females.

Haga N, Yoshida M, Mitsui T, Sekido N, Masumori N, Omae K BJUI Compass. 2025; 6(2):e70004.

PMID: 39963579 PMC: 11830994. DOI: 10.1002/bco2.70004.


Cardiometabolic Index and Stress Urinary Incontinence in US Women: The Mediating Role of the Triglyceride Glucose Index.

Yang Q, Cao Y Int Urogynecol J. 2025; .

PMID: 39812814 DOI: 10.1007/s00192-025-06044-x.


Genetic support of causal association between lipid and glucose metabolism and stress urinary incontinence in women: a bidirectional Mendelian randomization and multivariable-adjusted study.

Xiang N, Su S, Yang Y, Luo Y, Fu T, Wang L Front Endocrinol (Lausanne). 2024; 15:1394252.

PMID: 39351534 PMC: 11439682. DOI: 10.3389/fendo.2024.1394252.


Risk factors associated with the severity of overactive bladder among Syrian patients with type 2 diabetes.

Khadour F, Khadour Y, Alhatem W, Barroush D Sci Rep. 2024; 14(1):16547.

PMID: 39020001 PMC: 11255225. DOI: 10.1038/s41598-024-67326-w.


The association between non-alcoholic fatty liver disease and urinary incontinence among adult females in the United States.

Li X, Zhou W, Hu G BMC Public Health. 2024; 24(1):1373.

PMID: 38778285 PMC: 11110403. DOI: 10.1186/s12889-024-18578-8.


References
1.
. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

2.
Hendrix S, Cochrane B, Nygaard I, Handa V, Barnabei V, Iglesia C . Effects of estrogen with and without progestin on urinary incontinence. JAMA. 2005; 293(8):935-48. DOI: 10.1001/jama.293.8.935. View

3.
Subak L, Whitcomb E, Shen H, Saxton J, Vittinghoff E, Brown J . Weight loss: a novel and effective treatment for urinary incontinence. J Urol. 2005; 174(1):190-5. PMC: 1557356. DOI: 10.1097/01.ju.0000162056.30326.83. View

4.
Jackson S, Scholes D, Boyko E, Abraham L, Fihn S . Urinary incontinence and diabetes in postmenopausal women. Diabetes Care. 2005; 28(7):1730-8. DOI: 10.2337/diacare.28.7.1730. View

5.
Lifford K, Curhan G, Hu F, Barbieri R, Grodstein F . Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Soc. 2005; 53(11):1851-7. DOI: 10.1111/j.1532-5415.2005.53565.x. View